Manuel Dómine
Universidad de Las Palmas de Gran Canaria
2 papers in the Anchorcite directory, published between 2015 and 2018, cited 15,305 times in total.
ORCID profileResearch topics
- Cancer Immunotherapy and Biomarkers · 2 papers
- Lung Cancer Diagnosis and Treatment · 2 papers
- Lung Cancer Treatments and Mutations · 2 papers
Frequent co-authors
- Marina Chiara Garassino · 2 papers
- Julie Renee Brahmer · 1 paper
- Karen L. Reckamp · 1 paper
- Lucio Crinò · 1 paper
- Wilfried Eberhardt · 1 paper
- Elena V Poddubskaya · 1 paper
- Scott Joseph Antonia · 1 paper
- Adam Płużański · 1 paper
Papers
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung CancerNew England Journal of Medicine · 2015 · 8,551 citations
BACKGROUND: Patients with advanced squamous-cell non-small-cell lung cancer (NSCLC) who have disease progression during or after first-line chemotherapy have limited treatment options. This randomized, open-label, international, phase 3 study evaluated the efficacy and safety of nivolumab, a fully human IgG4…
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung CancerNew England Journal of Medicine · 2018 · 6,754 citations
BACKGROUND: First-line therapy for advanced non-small-cell lung cancer (NSCLC) that lacks targetable mutations is platinum-based chemotherapy. Among patients with a tumor proportion score for programmed death ligand 1 (PD-L1) of 50% or greater, pembrolizumab has replaced cytotoxic chemotherapy as the…
Metadata from OpenAlex (CC0).